Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Anpec

Anpec
In stock
40mg · 120mg
from A$29.67
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$35.61A$29.67
A$0.49 per tablet

In brief

  • In our pharmacy, you can buy anpec without a prescription in Australia; available over the counter in selected pharmacies and online with discreet packaging and delivery options.
  • Anpec (verapamil) is used for hypertension, angina pectoris, prevention and treatment of certain supraventricular arrhythmias (SVT, atrial fibrillation/flutter) and for migraine prophylaxis. It is a non‑dihydropyridine calcium‑channel blocker (phenylalkylamine) that inhibits L‑type calcium channels, reducing cardiac contractility, slowing AV node conduction and producing vasodilation.
  • Usual adult doses: oral immediate‑release 80–120 mg three times daily for hypertension/angina; oral maintenance/arrhythmia dosing often 240–320 mg/day in divided doses (extended‑release formulations vary 120–360 mg once daily); migraine prophylaxis 80–160 mg two‑to‑three times daily. IV for acute rhythm control: 2.5–10 mg slow IV bolus (dose reduced in children/under specialist care).
  • Forms: oral tablets (immediate‑release), extended‑release tablets/capsules (various strengths), and intravenous solution (ampoules for slow IV bolus/infusion).
  • Onset: oral immediate‑release usually begins within 30–60 minutes (extended‑release formulations take longer, often several hours); intravenous administration works within minutes (typically 1–5 minutes).
  • Duration of action: immediate‑release formulations last about 6–8 hours; sustained/extended‑release products provide effects from ~12 hours up to 24 hours depending on formulation.
  • Alcohol warning: avoid or limit alcohol while taking anpec — alcohol can increase dizziness and low blood pressure and enhance sedative effects.
  • The most common side effec is constipation.
  • Would you like to try anpec without a prescription?

Basic Anpec Information

  • INN (International Nonproprietary Name): Verapamil
  • Brand Names Available In Australia: Isoptin; Isoptin SR (listed for Australia in product information); other global brands include Calan, Calan SR, Verelan, Verelan PM, Covera‑HS and combination products such as Tarka.
  • ATC Code: C08DA01
  • Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended‑release 120 mg, 180 mg, 240 mg, 360 mg; ER capsules 100–360 mg strengths; IV solution 2.5 mg/mL supplied in 2 mL or 5 mL ampoules.
  • Manufacturers In Australia: Local availability commonly supplied by Abbott (Isoptin); global suppliers include Viatris (formerly Mylan), Teva, Pfizer, Gedeon Richter and Sanofi.
  • Registration Status In Australia: Brand Isoptin is listed for Australia in supplied product information; verify specific ARTG registration and approved pack sizes on the TGA website for current details.
  • OTC / Rx Classification: Prescription (Rx) only in most territories; verapamil is not an over‑the‑counter medicine.

Critical Warnings & Restrictions

Are there situations where verapamil must not be used?

Verapamil is a prescription‑only calcium‑channel blocker used for hypertension, angina and some arrhythmias.

Absolute contraindications from product data include severe hypotension with systolic blood pressure below 90 mmHg.

Advanced atrioventricular (AV) block is contraindicated unless the patient has a functioning pacemaker.

Sick sinus syndrome is a contraindication unless a pacemaker is in place.

Cardiogenic shock and decompensated heart failure are absolute contraindications.

Wolff‑Parkinson‑White syndrome with atrial fibrillation is contraindicated for verapamil use.

Known hypersensitivity to verapamil or any excipients is an absolute contraindication.

Extreme caution is required in liver disease because verapamil is extensively metabolised by the liver.

Severe renal impairment requires close monitoring although routine dose change is not always necessary.

Combination with beta‑blockers or digoxin increases the risk of bradycardia and conduction block and needs careful monitoring.

Elderly patients often need lower starting doses and closer follow‑up due to increased sensitivity and comorbidities.

Pregnant and breastfeeding people should use verapamil only if the expected benefit justifies the potential risk and under specialist advice.

Immediate red flags checklist — seek urgent care for syncope, chest pain, severe bradycardia or hypotension.

Use an emergency action checklist in the pharmacy and refer promptly to emergency services or the patient’s GP when red‑flag signs appear.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Are older people or those with other illnesses at higher risk?

Elderly patients require lower initial doses and gradual titration because of altered pharmacokinetics and comorbidities.

People with significant hepatic impairment need dose reduction and close monitoring because verapamil undergoes extensive hepatic metabolism.

Renal impairment usually does not require routine dose change unless severe, but monitor for hypotension and bradycardia.

Pregnancy and breastfeeding are special situations where specialist input is recommended and alternatives considered where possible.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will verapamil affect my ability to drive or work safely?

Verapamil can cause dizziness, drowsiness and blurred vision in some patients.

Patients should not drive or operate heavy machinery until they know how verapamil affects them.

Employers and safety‑critical workers in roles such as heavy vehicle driving, aviation or mining must follow workplace health rules and notify treating clinicians where required.

Q&A — “Can I Drive After Taking It In Australia?”

Q: Will verapamil affect my driving licence or ability to work?

A: Possibly.

A: If you experience dizziness, lightheadedness, significant drowsiness or blurred vision after starting or changing dose, do not drive or operate machinery.

A: For safety‑critical roles check your employment health policies and, if unsure, seek written advice from your GP or treating cardiologist.

A: Report adverse effects to your pharmacist and consider notifying the RMS or your employer where legally required.

Usage Basics

What names and preparations should patients look for in Australia?

INN, Brand Names Available In Australia

The international nonproprietary name is verapamil.

Common brand names present globally include Isoptin and Isoptin SR, which are listed for Australia in the supplied product information.

Other global brands include Calan, Calan SR, Verelan and Verelan PM, though local availability varies by supplier and sponsor.

Packaging commonly comes in blisters of 30, 50 or 100 tablets and extended‑release formats in 30 or 60 packs.

IV ampoules are typically 2 mL or 5 mL containing 2.5 mg/mL verapamil for specialist use.

If a patient searches for “Anpec” alongside verapamil, verify whether Anpec is the supplier or brand on the packaging or ARTG listing and always confirm the active ingredient is verapamil.

Legal Classification (TGA‑Approved, PBS‑Listed)

Is verapamil subsidised or available without a prescription?

Verapamil is prescription‑only in most jurisdictions and is listed by the WHO as an essential medicine.

Check the TGA ARTG for specific registered Australian products and consult the PBS schedule for subsidy status for particular formulations and indications.

Pharmacists must dispense on a valid prescription; e‑prescriptions and telehealth scripts are acceptable under Australian telehealth rules.

  • Required documentation: valid prescription for verapamil.
  • Required documentation: photo ID where pharmacy policy or controlled medicines require verification.
  • E‑prescription steps: prescriber issues e‑script, patient provides token or script ID, pharmacy receives and dispenses on receipt of the valid e‑script.

Dosing Guide

How is verapamil commonly dosed for different conditions?

Standard Regimens (PBS Reference Dosing)

Typical adult oral dosing for immediate‑release preparations is 80–120 mg by mouth three times daily for hypertension and angina.

Maintenance and arrhythmia control frequently require total daily doses in the range of 240–320 mg per day given in divided doses.

Extended‑release preparations are available in once‑daily strengths from 120 mg up to 360 mg depending on formulation and clinical need.

IV dosing for acute supraventricular tachycardia or rate control is a specialist procedure and typically uses slow boluses of 2.5–10 mg under monitoring.

Indication Typical Oral Dose ER vs IR Guidance IV Notes
Hypertension 80–120 mg PO three times daily IR for multiple doses; ER for once‑daily control (120–360 mg) Not routine
Angina 80–120 mg PO three times daily ER provides steadier symptom control Not routine
Supraventricular Arrhythmia 240–320 mg/day in divided doses ER for maintenance; IR may be used for titration 2.5–10 mg slow IV bolus in monitored setting
Migraine Prophylaxis 80–160 mg PO two to three times daily Trial over weeks; not first line Not applicable

Adjustments For Comorbidities

What dose changes should be considered with other illnesses?

Elderly patients should start at a low dose and titrate slowly while monitoring blood pressure and heart rate.

Hepatic impairment requires dose reduction and closer monitoring because verapamil is extensively metabolised by the liver.

Renal impairment usually does not require routine dose change unless severe, but observe for hypotension and bradycardia.

When combined with beta‑blockers, reduce doses and monitor ECG and vital signs due to additive effects on AV conduction and heart rate.

Q&A — “What If I Miss A Dose?”

Q: Missed tablet — what to do?

A: Take the missed dose as soon as you remember unless it is almost time for the next scheduled dose.

A: Do not take a double dose to make up for a missed tablet.

A: For once‑daily ER products, skip the missed dose if it is close to the next dose time.

A: When unsure, contact your pharmacist or GP for specific advice about your formulation and schedule.

Interaction Chart

Which foods, drinks and medicines interact with verapamil?

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol can potentiate hypotension and dizziness, so patients should be counselled to moderate intake and avoid binge drinking while starting or titrating verapamil.

Caffeine does not have a clinically significant pharmacokinetic interaction with verapamil but may worsen palpitations in some patients.

Grapefruit and grapefruit juice can increase plasma verapamil levels by inhibiting CYP3A4 and should be avoided or used consistently only after prescriber discussion.

Common Drug Conflicts

Many clinically important interactions exist and require action.

Interacting Drug Effect Recommended Action
Beta‑blockers Additive AV block and bradycardia Use with caution; reduce doses and monitor ECG and vitals
Digoxin Verapamil can increase digoxin levels Monitor digoxin levels and reduce dose if required
Strong CYP3A4 inhibitors (e.g. certain macrolides, azole antifungals) Increase verapamil exposure and risk of adverse effects Avoid or reduce dose and monitor closely
CYP3A4 inducers Reduce verapamil exposure and efficacy Monitor clinical response and consider dose adjustment
Statins metabolised by CYP3A4 Increased statin levels and risk of myopathy Use statins less reliant on CYP3A4 or monitor for myopathy

Immediate stop and urgent care is required if severe bradycardia or hypotension occurs, particularly if occurring after combining IV beta‑blockers and verapamil.

User Reports & Trends

What do Australian patients commonly tell pharmacists about verapamil?

Common tolerability complaints seen in pharmacy counselling and public forums include constipation, dizziness, peripheral oedema and fatigue.

Constipation is one of the most frequently reported adverse effects and often prompts patients to consult the pharmacist.

Patients on ER or SR formulations often report improved convenience and steadier control, while some note slower onset when used for angina relief.

Cost sensitivity is a recurrent theme in Australia with many patients asking about PBS subsidy, generics such as verapamil generics from Viatris or Teva and cheaper supply options through major chains.

Brand loyalty (Isoptin versus generics) sometimes relates to perceived differences in tolerability or efficacy when switching products.

  • Top 5 Patient Concerns: side effects (constipation, dizziness), cost, dosing complexity, driving and workplace safety, switching brands.

Recommended actions for pharmacists include documenting adverse effects, reporting through the TGA Adverse Medicines Events reporting system and offering pharmacist‑led medication reviews.

Access & Purchase Options

Where can Australians obtain verapamil and how do they buy it online?

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Major pharmacy chains typically stock Isoptin or generic verapamil in common strengths, though specific pack sizes and ER strengths vary between stores.

Price comparison across chains is common among Australian customers because out‑of‑pocket cost varies by brand and pack size.

Pharmacists can advise on generic equivalents and substitution rules under pharmacy regulation.

Online Pharmacies And Telehealth E‑Prescriptions

Telehealth e‑prescriptions are accepted for verapamil and online pharmacies may dispense after receiving a valid e‑script.

Rural patients often use online ordering and home delivery to access specific strengths or ER formulations that are not regularly stocked locally.

In our online pharmacy, anpec is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Checklist for filling a script online: provide a valid prescription or e‑script token, supply ID as required, supply Medicare details if PBS claim is to be made, and provide a delivery address.

Pharmacies must ensure ARTG product match and comply with substitution laws when dispensing a different brand or generic product.

Mechanism & Pharmacology

How does verapamil work in plain clinical terms?

Simplified Explanation

Verapamil is a non‑dihydropyridine calcium‑channel blocker that inhibits L‑type calcium channels in cardiac and vascular smooth muscle.

This action reduces myocardial contractility, slows atrioventricular nodal conduction and causes vasodilation.

The combined effects are useful for angina, hypertension and supraventricular arrhythmias.

Clinical Terms

Key effects include negative chronotropy, which slows the heart rate, and negative inotropy, which reduces contractile force.

AV nodal suppression makes verapamil useful for rate control in supraventricular tachycardias and atrial fibrillation but also explains contraindications in conduction disease.

Verapamil undergoes extensive hepatic first‑pass metabolism and has active metabolites that vary by formulation.

Extended‑release formulations provide smoother plasma levels and often improve adherence and tolerability compared with immediate‑release forms.

  1. Mechanism: L‑type calcium‑channel blockade in heart and vessels.
  2. Clinical Effect: Reduced heart rate, decreased contractility, vasodilation.
  3. Clinical Implication: Risk of AV block → contraindicated in advanced conduction disease unless pacemaker present.

Prescribers should monitor ECG, blood pressure and heart rate after initiation or dose changes.

Indications & Off‑Label Uses

What is verapamil officially approved to treat and where is it used off‑label?

Approved Indications By TGA (And Typical Use)

Verapamil is used for hypertension, stable angina and certain supraventricular arrhythmias such as supraventricular tachycardia and rate control in atrial fibrillation or flutter.

IV verapamil is used acutely for SVT conversion in a specialist setting under monitoring.

Indication Common Adult Dose Typical Course
Hypertension 80–120 mg PO three times daily or ER once daily Chronic long‑term therapy with periodic review
Stable Angina 80–120 mg PO three times daily or ER equivalent Chronic therapy to reduce anginal episodes
SVT / AF Rate Control 240–320 mg/day in divided doses Acute IV for conversion; oral for maintenance
Migraine Prophylaxis 80–160 mg PO two to three times daily Trial over weeks to months

Off‑Label Uses In Australian Clinical Practice

Off‑label uses include select paediatric acute SVT management by IV verapamil under specialist care with weight‑based dosing.

Occasionally verapamil is used for cluster headaches or refractory migraine prophylaxis when other agents have failed, with specialist oversight.

All off‑label uses should be documented with informed consent and specialist involvement where appropriate.

Always cross‑check the TGA ARTG entries and local hospital guidance before use in pregnancy, paediatrics or other special populations.

Key Clinical Findings

What does the evidence say about verapamil’s benefits and risks?

Verapamil’s efficacy for rate control in SVT and certain supraventricular arrhythmias is well established in clinical practice.

Verapamil reduces angina symptoms and lowers blood pressure in hypertensive patients when used as part of a management plan.

Comparative effectiveness versus diltiazem and beta‑blockers depends on indication; non‑dihydropyridines like verapamil have stronger AV nodal effects than dihydropyridines.

Recent literature from 2022–2026 should be checked on PubMed, Cochrane, RACGP and Heart Foundation guidance for the latest RCTs and meta‑analyses.

Do not rely on single small studies; prioritise guideline recommendations and larger trials for prescribing decisions.

  • Key endpoints to review in trials: mortality, symptom control, rate control efficacy and adverse event profiles.

E‑E‑A‑T note: consult authoritative sources such as the TGA, Heart Foundation and peer‑reviewed journals when making prescribing decisions.

Alternatives Matrix

What are practical alternatives listed on the PBS for common verapamil indications?

PBS‑Listed Alternatives Comparison Table

Drug PBS Status Mechanism Main Pros Main Cons Monitoring Needs
Diltiazem Check PBS schedule Non‑dihydropyridine CCB Similar AV nodal effects; alternative if verapamil intolerable Can cause bradycardia and hypotension BP, HR, ECG as indicated
Amlodipine PBS listed for some indications Dihydropyridine CCB Good for hypertension, less AV node effect Peripheral oedema common BP monitoring
Beta‑Blockers Various PBS listings Adrenergic blockade Effective for angina and rate control Avoid in severe reactive airways disease BP, HR, respiratory status

Pros And Cons Checklist

Diltiazem: similar AV nodal effects and may be preferred if verapamil is not tolerated.

Amlodipine: useful where bradycardia is a concern and in hypertension management, but expect more peripheral oedema.

Beta‑blockers: effective for angina and arrhythmia control but contraindicated or used with caution in reactive airways disease.

When switching, confirm the indication, check interactions (especially with digoxin or combined beta‑blocker therapy), counsel on side‑effect differences and perform baseline vitals and ECG where indicated.

Common Questions

What do patients ask most in the pharmacy about verapamil?

  • Q: Will verapamil make me constipated? A: Yes, constipation is common; increase dietary fibre and fluids and discuss stool softener options with the pharmacist.
  • Q: Can I switch brands/generics? A: Generally yes, but monitor for any change in symptoms or side effects and report issues; pharmacists can substitute within regulation.
  • Q: Pregnancy/breastfeeding? A: Use only if necessary and after discussion with an obstetrician; verapamil is excreted in breastmilk.
  • Q: How long until it works? A: Immediate‑release formulations act over hours for BP and angina; ER forms take longer but provide steadier control; migraine prophylaxis may take weeks to assess benefit.

When to contact GP: syncope, chest pain, severe dizziness or any worrying new cardiac symptoms.

When to attend ED: severe hypotension, marked bradycardia, loss of consciousness or signs of cardiac arrest.

Price & Access Comparison Table

Where to compare prices and access options in Australia?

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range PBS Subsidy Prescription Required
Chemist Warehouse Varies by brand and pack size Check PBS Schedule Yes
Priceline Varies by brand and pack size Check PBS Schedule Yes
TerryWhite Chemmart Varies by brand and pack size Check PBS Schedule Yes
Independent Pharmacies Varies Check PBS Schedule Yes
Online Pharmacies Varies; includes delivery fees Check PBS Schedule Yes

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

Confirm pack size and formulation (IR vs ER) before purchase.

Ask the pharmacist about generic alternatives such as products from Viatris, Teva or other manufacturers.

Request PBS concession pricing if eligible and verify delivery times for rural areas.

Remember that price comparisons can exclude pharmacist consultation fees and additional dispensing charges.

Registration & Regulation

How are verapamil products regulated and where to verify registration?

TGA Approval

Verify specific verapamil products on the TGA ARTG to confirm registration details, approved indications and approved pack sizes for Australia.

The supplied product data indicates Isoptin is marketed in Australia; consult ARTG entries for the local sponsor and pack details.

PBS Subsidy Details

PBS listing varies by formulation, indication and strength and may change over time.

Clinicians and pharmacists should consult the PBS Schedule and local HealthPathways for up‑to‑date subsidy criteria and prescribing rules.

Regulatory Source What It Provides
TGA ARTG Registration status, sponsor, approved pack sizes and product details
PBS Schedule Subsidy status, prescribing criteria and patient contribution details
Heart Foundation / RACGP Guidance Clinical guidance for cardiovascular indications and management

Dispensing must meet TGA labelling and PBS prescription rules and pharmacists should document substitutions when required.

Storage & Handling

How should verapamil be stored at home and in pharmacy?

Household Storage In Australian Climate (Heat/Humidity)

Tablets and capsules should be stored below 25°C, kept dry and protected from direct light.

Advise patients in hot or humid Australian climates to store medications in a cool, dry cupboard away from the bathroom or windowsill.

Keep all medicines out of reach and sight of children.

Cold‑Chain Handling For Pharmacies

IV solution ampoules should be protected from light and must not be frozen.

Discard ampoules if discoloured or if the ampoule has been opened.

Pharmacies should liaise with wholesalers about ambient temperature shipping arrangements for hot months and follow local cold‑chain and storage protocols where applicable.

Travellers checklist: carry medicine in original packaging, keep at controlled temperature, obtain GP letter for airport security and plan supplies when travelling for longer periods.

Guidelines For Proper Use

What should pharmacists tell patients when dispensing verapamil?

Australian Pharmacist Counselling Style

State the INN verapamil and the brand dispensed and confirm the indication with the patient.

Explain the dosing schedule and highlight the difference between immediate‑release and extended‑release formulations.

Discuss common side effects such as constipation, dizziness and peripheral oedema and give simple management tips.

Explain important interactions with alcohol, grapefruit and other medicines and advise when to seek urgent care.

Use teach‑back to confirm the patient understands dosing times, safety precautions and when to call for help.

Patient Advice From PBS And National Health Authorities

Provide a written dosing plan and encourage regular monitoring of blood pressure and pulse as appropriate.

Arrange follow‑up with the GP or pharmacist after initiation or dose adjustment.

Advise patients to report adverse reactions to the TGA via the Adverse Medicines Events system.

Overdose signs such as severe hypotension, bradycardia, confusion or cardiac arrest require immediate attendance at the emergency department.

Emergency care for overdose may include gastric decontamination, IV fluids, vasopressors and intravenous calcium gluconate as indicated in emergency protocols.

Monitoring When
Blood Pressure and Heart Rate Baseline, after initiation and after dose changes
ECG Where conduction disease suspected or when combining with other rate‑slowing drugs
Constipation Management Advise fibre, fluids and stool softener if needed

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days

Related products